Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	163.61	994.59	377.29
Graham Fair Price	-29.67	6895.99	9805.81
PEG	93.27	-5.53	-82.13
Price/Book	9.93	10.77	9.79
Price/Cash Flow	-105.48	-91.45	-44.51
Prices/Earnings	126.69	281.92	124.36
Price/Sales	-19.30	42.64	52.84
Price/FCF	-105.48	-91.45	-44.51
Naive Interpretation	member

01 - Valuation · Bad

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-38.16	0.09	0.15
Operating Margin	-56.12	0.04	0.10
ROA	-49.25	< 0.005	0.01
ROE	0.02	< 0.005	-51.51
ROIC	0.02	< 0.005	-62.64
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.05	-0.45	89.04
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.08	-0.40	380.11
EPS QOQ	-0.02	-0.51	-3269.63
FCF QOQ	-6.13	0.46	-92.50
Revenue QOQ	-0.42	0.38	-11.50
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	197.17	106.26	-46.11
Days Sales Outstanding (DSO)	68.40	68.80	0.60
Inventory Turnover	0.46	0.85	85.55
Debt/Capitalization	0.10	0.10	-5.57
Quick Ratio	0.80	0.59	-25.99
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	14732.22	14877.79	0.99
Cash	1907.65	60.77	-96.81
Capex	-1090.48	-2649.93	-143.01
Free Cash Flow	-3242.25	-1751.74	45.97
Revenue	2731.01	3757.04	37.57
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.83	1.41	-22.92
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-0.34	10.04	2859.66
Naive Interpretation	Member

06 - Financial Health · Weak

Rating